Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | DNAJA4 |
| Upstream (Parents) |
|---|
| (<<) ATF4 → DNAJA4 |
| (<<) ATP7B → DNAJA4 |
| (<<) BMP8B → DNAJA4 |
| (<<) CDKN2A → DNAJA4 |
| (<<) COIL → DNAJA4 |
| (<<) MAP6D1 → DNAJA4 |
| (<<) MEF2D → DNAJA4 |
| (<<) MTRR → DNAJA4 |
| (<<) PTAFR → DNAJA4 |
| (<<) RARA → DNAJA4 |
| (<<) RCBTB1 → DNAJA4 |
| (<<) SEPW1 → DNAJA4 |
| (<<) SOX3 → DNAJA4 |
| (<<) UBE2E3 → DNAJA4 |
| Downstream (Children) |
|---|
| DNAJA4 → CEBPE (>>) |
| DNAJA4 → EGF (>>) |
| DNAJA4 → ITGB7 (>>) |
| DNAJA4 → MAPK11 (>>) |
| DNAJA4 → ME1 (>>) |
| DNAJA4 → NEUROG1 (>>) |
| DNAJA4 → NLGN4Y (>>) |
| DNAJA4 → RPL35A (>>) |
| DNAJA4 → WNT4 (>>) |
| DNAJA4 → WNT7A (>>) |
